FORMULATION AND EVALUATION OF NANOSUSPENSION OF ROSUVASTATIN CALCIUM
Poor water solubility and slow dissolution rate are issues for majority of upcoming and existing biologically active compounds. The aim of present work was to increase the dissolution rate of Rosuvastatin Calcium, a poorly water soluble drug and hence improve its oral bioavailability by Nanosuspension technology. Nanosuspension is new carrier free colloidal drug delivery system with nano sized particles below 1000 nm, and considered as a great drug delivery technique to enhance the drug dissolution and solubility. In the present work Nanosuspension is made by nanoprecipitation technique in the presence of sodium lauryl sulfate as surfactant and PVPK-30 as stabilizer. Prepared Nanosuspension was evaluated for its particle size study, in vitro dissolution study and characterized by Screening Electron microscopy (SEM).
Different concentrations of sodium lauryl sulphate (SLS) and PVPK-30 were evaluated. All formulations were in the nano size and showed marked improvement in dissolution and solubility compared to pure drug of micron size. Finally it was concluded that formulating poorly soluble drugs in the form of Nanosuspension would be a promising approach in delivery of poor water soluble drugs by oral route in a simple and effective way.
2. Lipinski C. Poor Aqueous Solubility-An Industry Wide Problem in Drug Discovery. Am. Pharm. Rev. 2002; 5: 82
3. Kipp J, Wong JCT, Dotty MJ and Rebbech Cl. Microprecipitation Method of Preparing Submicron Suspension. U.S. PATENT; 2003.
4. Hassan MA, Suleiman MS, Najib NM. Int J Pharm. 1990; 58: 19–24.
5. Rania HF, Mohammed AK. Eur J Pharm Biopharm. 2008; 69: 993–1003.
6. Patel DJ, Pandya VM, Patel JK. Int J Pharm Research. 2009; 1(4): 21-27.
7. Patel DJ, Patel JK, Pandya VM, Patel RD. Int J Pharma Sci Nano. 2010; 4(2): 707-13.
The International Journal of Drug Regulatory affairs require a formal written transfer of copyright from the author(s) for each article published. We therefore ask you to complete and return this form, retaining a copy for your records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication.
I/we have read and agree with the terms and conditions stated Page 2 of this agreement and I/we hereby confirm the transfer of all copyrights in and relating to the above-named manuscript, in all forms and media, now or hereafter known, to the International Journal of Drug Regulatory affairs, effective from the date stated below. I/we acknowledge that the IJDRA is relying on this agreement in publishing the above-named manuscript. However, this agreement will be null and void if the manuscript is not published in the IJDRA.
Download link for COPYRIGHT FORM